<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The objective of this study is to determine if digital <z:hpo ids='HP_0002633'>vasculitis</z:hpo> (DV), a clinical manifestation with a high <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> disease activity index (SLEDAI) score, is associated with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> severity </plain></SENT>
<SENT sid="1" pm="."><plain>DV and other clinical manifestations defined according to the SLEDAI were evaluated in 168 consecutive patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="2" pm="."><plain>Two groups were defined according to presence (DV+, n = 27) or absence of DV (DV-, n = 141) at the time of evaluation </plain></SENT>
<SENT sid="3" pm="."><plain>The exclusion criterion was the presence of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (Sapporo's criteria) </plain></SENT>
<SENT sid="4" pm="."><plain>The two groups were comparable with regard to age (P = 0.09), gender (P = 1.00), white race (P = 0.81), and disease duration (P = 0.78) </plain></SENT>
<SENT sid="5" pm="."><plain>Compared to the DV- group, the DV+ group had a significantly higher frequency of mucocutaneous manifestations (66.7 vs. 39.0%, P = 0.01), <z:e sem="disease" ids="C0850715" disease_type="Disease or Syndrome" abbrv="">haematological abnormalities</z:e> (22.2 vs. 6.4%, P = 0.02) and constitutional symptoms (11.1 vs. 0.7%, P = 0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>Renal and neurological involvements were similar in both groups (P = 0.57 and P = 1.00, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>The evaluation of each SLEDAI parameter confirmed that the DV+ group had higher frequencies of mild manifestations, such as new <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> (P = 0.02), <z:hpo ids='HP_0001596'>alopecia</z:hpo> (P = 0.02), <z:hpo ids='HP_0000155'>oral ulcers</z:hpo> (P = 0.045), <z:hpo ids='HP_0001945'>fever</z:hpo> (P = 0.01) and <z:e sem="disease" ids="C0023530" disease_type="Disease or Syndrome" abbrv="">leucopenia</z:e> (P = 0.005) </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, both groups had similarly increased anti-dsDNA (P = 0.78) and decreased complement levels (P = 0.29) </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, DV in patients with SLE identifies a subgroup of a mild disease </plain></SENT>
<SENT sid="10" pm="."><plain>The high 'weighted' index attributed to this alteration in the SLEDAI score should therefore be revised </plain></SENT>
</text></document>